Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mimran

Showing results (141-150 of 262) with videos related to

Pageof 27
Sort By:
Clinical Nephrology|February 1, 1978
The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patientsA Mimran, S Shaldon, P Barjon, et al.
Journal of Hypertension|October 26, 2001
Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertensionB Jover, A Herizi, D Casellas, et al.
Hypertension (Dallas, Tex. : 1979)|February 4, 1998
Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockadeA Herizi, B Jover, N Bouriquet, et al.
Nephrologie|January 1, 1982
[Reversible acute renal failure and nephrotic syndrome induced by fenoprofene ]G Mourad, A Mimran, P Baldet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1984
[Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system]B Jover, M Dupont, D Casellas, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1991
Effect of the angiotensin antagonist DuP 753 on the renal adaptation to sodium restriction in the ratB Jover, M Dupont, E Nafrialdi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1979
The renin-angiotensin system and the antihypertensive effect of atenolol in manA Mimran, G Deschodt, J Fourcade, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|February 1, 1972
Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?P Barjon, J Fourcade, A Mimran, et al.
Canadian Journal of Physiology and Pharmacology|November 20, 1997
Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptideJ P Valentin, J Ribstein, N Nafrialdi, et al.
The American Journal of Physiology|April 1, 1990
Role of atrial peptide in the acute natriuretic response to uninephrectomyJ P Valentin, J Ribstein, E Pussard, et al.
Pageof 27

Showing results (141-150 of 262) with videos related to

Sort By:
Pageof 27
Clinical Nephrology|February 1, 1978
The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patientsA Mimran, S Shaldon, P Barjon, et al.
Journal of Hypertension|October 26, 2001
Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertensionB Jover, A Herizi, D Casellas, et al.
Hypertension (Dallas, Tex. : 1979)|February 4, 1998
Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockadeA Herizi, B Jover, N Bouriquet, et al.
Nephrologie|January 1, 1982
[Reversible acute renal failure and nephrotic syndrome induced by fenoprofene ]G Mourad, A Mimran, P Baldet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1984
[Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system]B Jover, M Dupont, D Casellas, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1991
Effect of the angiotensin antagonist DuP 753 on the renal adaptation to sodium restriction in the ratB Jover, M Dupont, E Nafrialdi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1979
The renin-angiotensin system and the antihypertensive effect of atenolol in manA Mimran, G Deschodt, J Fourcade, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|February 1, 1972
Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?P Barjon, J Fourcade, A Mimran, et al.
Canadian Journal of Physiology and Pharmacology|November 20, 1997
Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptideJ P Valentin, J Ribstein, N Nafrialdi, et al.
The American Journal of Physiology|April 1, 1990
Role of atrial peptide in the acute natriuretic response to uninephrectomyJ P Valentin, J Ribstein, E Pussard, et al.
Pageof 27